CG Oncology CGON Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's operating income?
- CG Oncology (CGON) reported operating income of -$66.39M in Q1 2026.
- How has CG Oncology's operating income changed year-over-year?
- CG Oncology's operating income decreased by 57.3% year-over-year, from -$42.2M to -$66.39M.
- What is the long-term trend for CG Oncology's operating income?
- Over 2 years (2023 to 2025), CG Oncology's operating income has grown at a 85.5% compound annual growth rate (CAGR), from -$55.45M to -$190.77M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.